Isosorbide-5-mononitrate 50 mg for the management of coronary aretry disease. In biphasic release formulation, 30% immediate release & 70% sustained release to provide risk adjusted protection with once daily dosage and nitrate free interval.
Isosorbide 5-mononitrate 50 mg in biphasic release formulation, 30% immediate release & 70% sustained release for risk adjusted protection.
Long term treatment of coronary artery disease. Prophylaxis of anginal attacks; post-treatment of myocardial infarction with persisting anginal symptoms; long term treatment of chronic congestive heart failure in combination with digitalis and/or diuretics; chronic cor pulmonale.
Headache (less frequent than with others) & subsides gradually upon continuing treatment).
Dosage and Administration
One to two capsules once daily.
In the Most recent Guidelines of the European Society of Cardiology (SCAD) for the management of Stable Coronary Aretry Disease (SCAD);
Nitrates were recommended for the relief of Angina/ Ischaemia.
Lipanthyl 300 is recommended for the treatment of hypercholesterolaemia (abnormally elevated levels of cholesterol in blood) and/or hypertriglyceridaemia (abnormally elevated levels of triglycerides).
Minapharm Pharmaceuticals receives regulatory approval from the Paul-Ehrlich Institute for a phase 1 multi-center clinical trial in Germany for its Adalimumab biosimilar
Bioventure, Minapharm Pharmaceuticals and MiGenTra Sign an Exclusive Agreement
for the Commercialization of Multiple Biosimilar Candidates of Alvotech
in the Middle East and Africa
As a global leader in biotechnology & cellular engineering, ProBioGen-Minapharm
As a continuation of Minapharm unique series of "Expert Panel",
The meeting was chaired by Prof. Abdel-Shakour EL MOHAMADY.
The First Netilmicin The Least Resistance
The First Netilmicin Combination the Quick Relief for Ocular Inflammation
Striking Glaucoma Treatment Goals Balancing EFFICACY, COMPLIANCE & AFFORADABILITY
Robust & long lasting correction of serum vitamin D levels For prophylaxis and/or treatment of vitamin D deficiency
Stay connected, subscribe to our newsletter for news and updates.